Pharmaceutical, analytical and clinical study on two dosage forms of Nyagrodhadigana in leucorrhea

Pharmaceutico-analytical and clinical study on two dosage forms of nyagrodhadi gana w.s.r. to Shwetapradara - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/01/079407

Enrollment

Registered

2025-01-24

Start date

Unknown

Completion date

Unknown

Last updated

2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N739- Female pelvic inflammatory disease, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patient complaining of white discharge per vagina as a cardinal symptom. Age group between 18 to 45 years.

Exclusion criteria

Exclusion criteria: Female less than 18 years of age and more than 45 years Unmarried girls Menopausal women Pregnant and lactating mother Any other chronic illness like carcinoma of cervix, uterine fibroid, vaginal polyp, chronic pelvic inflammatory diseases, cervical erosion.

Design outcomes

Primary

Measure	Time frame
Symptoms wise assessment parameters are, White discharge (Shwetastrav), Valval itching (yonikandu), Foul smell (yoni daurgandhya), Vaginal pain (yoni vedna), Prushth vedna (back ache), Daurbalya (weakness), Adhodar vedna (lower abdominal pain), Yoni daha (burning sensation in vagina).Timepoint: every 5th day for 15 days	—

Secondary

Measure	Time frame
to compare the improvements in secondary symptoms of shwetpradara like yonikandu, yonidourgandhya, yonivedna, prushtha vedna, daurbalya, adhoudar vedna, Yonidaha etc.Timepoint: every 5th day for 15 days	—

Countries

India

Contacts

Public ContactDr R K Pati

Pt. Khushilal Sharma government autonomous college and institute

patirajkishore@gmail.com9425677682

Outcome results